NCT04329299View on ClinicalTrials.gov

Use of Blood Biomarkers to Predict Gastric Cancer Risk

CompletedOBSERVATIONAL
Enrollment

6,862

Participants

Timeline

Start Date

December 3, 2012

Primary Completion Date

May 29, 2016

Study Completion Date

May 29, 2016

Conditions
Stomach Neoplasm
Interventions
DIAGNOSTIC_TEST

blood-based biomarkers analyses

Analyses of H. pylori antibodies/pepsinogen levels, micro RNAs (miRNAs) or blood-based protein markers levels in participants' blood samples

Trial Locations (2)

119074

National University Hospital, Singapore, Singapore

308433

Tan Tock Seng Hospital, Singapore, Singapore

All Listed Sponsors
collaborator

Tan Tock Seng Hospital

OTHER

collaborator

MiRXES Pte Ltd

INDUSTRY

lead

National University Hospital, Singapore

OTHER

NCT04329299 - Use of Blood Biomarkers to Predict Gastric Cancer Risk | Biotech Hunter | Biotech Hunter